Skip to main content

Table 1 Patient characteristics presenting at baseline

From: Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial

 

Safety/ITT population

Per protocol population

EFJ (N = 103)

VC (N = 98)

EFJ (N = 64)

VC (N = 75)

Age classes ( years)

 4–6 years

41 (39.8%)

32 (32.6%)

24 (37.5%)

28 (37.3%)

 > 7 years

62 (60.2%)

66 (67.4%)

40 (62.5%)

47 (62.7%)

Mean (SD)

7.8 (2.74)

8.1 (2.71)

8.1 (2.81)

7.9 (2.69)

Height [cm]

Mean (SD)

127.0 (16.35)

130.1 (16.37)

128.7 (16.42)

128.2 (16.33)

Body weight [kg]

Mean (SD)

28.1 (10.60)

29.1 (11.49)

28.8 (10.47)

28.1 (11.21)

Previous annual RTIs (SE)

3.2 (0.23)

3.3 (0.27)

3.2 (0.30)

3.4 (0.34)

Previous annual complicated RTIs (SE)

0.6 (0.09)

0.6 (0.09)

0.7 (0.13)

0.5 (0.08)

Attendance of school or kindergarten [yes (SD)]

93 (90.3%)

92 (93.9%)

60 (93.8%)

70 (93.3%)

  1. The age in years was calculated according to the formula: year of visit 1 – year of birth
  2. SD standard deviation, SE standard error mean, EFJ Echinaforce Junior tablets, VC vitamin C tablets